IIM- IDIOPATHIC INFLAMMATORY MYOPATHIES
Clinical trials for IIM- IDIOPATHIC INFLAMMATORY MYOPATHIES explained in plain language.
Never miss a new study
Get alerted when new IIM- IDIOPATHIC INFLAMMATORY MYOPATHIES trials appear
Sign up with your email to follow new studies for IIM- IDIOPATHIC INFLAMMATORY MYOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test 'Off-the-Shelf' cell therapy to reset immune system in devastating autoimmune diseases
Disease control Recruiting nowThis early-phase study is testing a new type of cell therapy called QT-019C for people with severe autoimmune diseases that have not improved with standard treatments. The therapy uses donated, 'universal' immune cells engineered to target and remove harmful immune cells. The mai…
Matched conditions: IIM- IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
New drug tested for patients with severe autoimmune diseases who have run out of options
Disease control Recruiting nowThis is a very early study to check the safety and initial effects of an experimental drug called CC312. It is for adults with severe, relapsed forms of lupus, myositis, or scleroderma that have not improved with standard treatments. The main goal is to find a safe dose and see h…
Matched conditions: IIM- IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: EARLY_PHASE1 • Sponsor: CytoCares Inc • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC